Pancreatic Cancer: Pathogenesis and Clinical Studies
ABSTRACT Pancreatic cancer (PC) is a highly lethal malignancy, with pancreatic ductal adenocarcinoma (PDAC) being the most common and aggressive subtype, characterized by late diagnosis, aggressive progression, and resistance to conventional therapies. Despite advances in understanding its pathogene...
Saved in:
| Main Authors: | Kexun Zhou, Yingping Liu, Chuanyun Tang, Hong Zhu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-04-01
|
| Series: | MedComm |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/mco2.70162 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nanomedicine in the Diagnosis and Treatment of Pancreatic Cancer
by: Kexin Guo, et al.
Published: (2025-03-01) -
Genetics and clinical implications of SPINK1 in the pancreatitis continuum and pancreatic cancer
by: Qi-Wen Wang, et al.
Published: (2025-03-01) -
Diagnostic and therapeutic recommendations in pancreatic ductal adenocarcinoma. Recommendations of the Working Group of the Polish Pancreatic Club
by: Katarzyna Winter, et al.
Published: (2019-03-01) -
Epigenetic silencing ZSCAN23 promotes pancreatic cancer growth by activating Wnt signaling
by: Qian Du, et al.
Published: (2024-12-01) -
Pancreatic ductal adenocarcinoma arising from the pancreatic parenchyma compressed by a huge pancreatic lipoma: a case report
by: Seiji Nakahara, et al.
Published: (2023-08-01)